[Form 4] Amkor Technology Inc Insider Trading Activity

Rhea-AI Filing Summary

Kandi Technologies Group, Inc. (KNDI) filed a Form S-8 to register up to 14,933,440 ordinary shares for equity compensation purposes.

• 730,345 unallocated shares remain available under the amended 2008 Omnibus LTIP.
• 4,203,095 shares are issuable upon exercise of outstanding stock options.
• 10,000,000 shares are reserved for the new 2025-2034 sub-plan.

The company had 82,044,298 shares outstanding on 30 Jul 2025; the newly registered amount represents roughly 18 % potential dilution if fully issued.

Kandi will receive no proceeds from insider resales, though cash from option exercises will fund general corporate needs. A re-offer prospectus allows employees, directors and officers to resell up to 4.2 M shares on Nasdaq (last close $1.12).

No new financial results or guidance are provided; referenced risks mirror those in the 2024 Form 20-F, including PRC regulatory, currency and enforcement uncertainties.

Positive

• Long-term incentive capacity: 10 M additional shares support employee retention and recruitment through 2034.
• Cash inflow potential: Company will receive option exercise proceeds, augmenting working capital without raising debt.
• Regulatory transparency: Re-offer prospectus simplifies insider resale compliance and may enhance trading liquidity.

Negative

• Dilution risk: Up to 14.9 M new shares equal roughly 18 % of current outstanding, potentially pressuring EPS and share price.
• No proceeds from resales: Secondary sales by insiders generate zero cash for the company yet can weigh on market supply.
• Overhang: Immediate registration of 4.2 M insider shares could signal forthcoming selling activity.

Insights

Financial Analyst

TL;DR: Registration adds up to 18% share overhang; neutral cash impact; helps retain talent but could pressure stock.

Detail: Form S-8 covers 14.9 M shares, materially enlarging the share pool of 82 M outstanding. While option exercise proceeds provide incremental working-capital cash, the company receives nothing from secondary resales. The filing contains no new operating data, so valuation is unaffected today; however, potential dilution and insider selling may cap upside until absorbed by the market. Overall, impact is modestly dilutive yet strategically necessary to attract key staff during the pivot to electric off-road vehicles.

Corporate Governance Specialist

TL;DR: Expanded incentive plan aligns management interests but raises dilution and governance monitoring needs.

The registration enables continued equity-based compensation through 2034, important for a China-based issuer competing for technical talent. Inclusion of a F-3 re-offer prospectus increases transparency by pre-clearing insider resales, reducing 144 complexity. Nevertheless, authorizing shares equal to ~18 % of the float without explicit shareholder approval heightens dilution risk. Investors should watch award vesting terms, option strike levels, and board oversight to ensure grants remain performance-linked.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

2023 Grantor Retained Annuity Trust of Agnes C. Kim Dated 4/26/2023

(Last) (First) (Middle)

C/O SIANA CARR O'CONNOR & LYNAM

1500 EAST LANCASTER AVENUE

(Street)

PAOLI PA 19301-9713

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AMKOR TECHNOLOGY, INC. [ AMKR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
	Officer (give title below)	X	Other (specify below)
			Member of 10% owner group (2)

3. Date of Earliest Transaction (Month/Day/Year)
07/30/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/30/2025		G		1,738,000(1)	D	$0	560,001	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. On July 30, 2025 the Reporting Person distributed 1,738,000 shares of the Common Stock of Amkor Technology, Inc. to Agnes C. Kim. Susan Y. Kim is the sole trustee of the Reporting Person.

Remarks:

(2) The Reporting Person states that the filing of this Form 4 shall not be deemed an admission that the Reporting Person is the beneficial owner of the reported securities owned by the other members of the group, for the purpose of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

	/s/ Brian D. Short, Attorney-in-Fact	08/01/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many new KNDI shares are being registered under this Form S-8?

A total of 14,933,440 ordinary shares are being registered: 730,345 unallocated, 4,203,095 option shares, and 10,000,000 for the 2025-2034 plan.

What percentage of KNDI's outstanding shares could this registration dilute?

If fully issued, the registered shares equal about 18 % of the 82,044,298 shares outstanding as of July 30 2025.

Will Kandi Technologies receive cash from the sale of these shares?

Kandi will not receive proceeds from insider resales, but it will obtain cash when employees exercise stock options.

What is the last reported Nasdaq price for KNDI shares?

The last reported sale price on 31 Jul 2025 was $1.12 per share.

Why include a re-offer prospectus in the S-8 filing?

It allows eligible insiders to resell up to 4.2 M shares to the public without further SEC registration, providing liquidity and compliance clarity.

What risks are highlighted in connection with this filing?

The prospectus references risks from the 2024 Form 20-F, including PRC regulatory uncertainties, currency controls, and market competition.